Definitive Healthcare Corp. · NASDAQ:DH
Definitive Healthcare — Q1 2022 Earnings Presentation
17 slides from Definitive Healthcare's earnings presentation, May 5, 2022
Slide 1: First quarter 2022 supplemental slides
First quarter 2022 supplemental slides May 5, 2022
Slide 2: Cautionary statement regarding forward-looking statements
Cautionary statement regarding forward-looking statements This following slides are part of a presentation by Definitive Healthcare Corp. (together with its subsidiaries, the contained in this presentation and no responsibility or liability whatsoever is accepted for the accuracy or “Company,” “we,”
Slide 3: Contents
Q1 results Contents Guidance Non-GAAP reconciliations & basis of presentation 3
Slide 4: Q1 results
Q1 results 4
Slide 5: Q1 performance
Q1 performance We delivered a 4% revenue beat that flowed through all profitability metrics $ IN MILLIONS, except per share info First Quarter 2022 Guidance Range Comments Revenue $50.1 $47.0 - 49.0 • Revenue - 4% or $2.1 million beat vs. midpoint % growth 36% 26% - 31% • Adj. Operating profit – 20%
Slide 6: Key shareholder statistics
Key shareholder statistics Key shareholder statistics as of 3/31/2022 Public Shares Minority Interest Comments Vested shares Combined (Class A Shares) (Class B Shares) • 554k class B shares were exchanged into class A Sponsor ownership (as-if converted) 65,806,532 30,960,392 96,766,924 public shares
Slide 7: Balance sheet highlights
Balance sheet highlights AS OF Comments $ IN MILLIONS, except net leverage ratio MARCH 31, 2022 MARCH 31, 2021 YoY Growth • Cash & Debt – Strong balance sheet positions Cash and cash equivalents $229.8 $33.1 $196.7 >100% us to move quickly to seize opportunities 1 Total debt outstanding $269.1 $461.
Slide 8: Guidance
Guidance 8
Slide 9: Q2 and full year 2022 guidance
Q2 and full year 2022 guidance (as of May 5, 2022) $ IN MILLIONS, except per share info Second Quarter 2022 2022 Comments Revenue $53.0 - 54.0 $220.5 - 224.5 • Full year revenue guidance increased by $2.5, % growth 33% - 36% 33% - 35% reflecting growth of between 33% and 35% Adjusted Operating Profi
Slide 10: Non-GAAP reconciliations & basis of presentation
Non-GAAP reconciliations & basis of presentation 10
Slide 11: GAAP gross profit to adjusted gross profit
Reconciliation from GAAP gross profit to adjusted gross profit THREE MONTHS ENDED MARCH 31, $ IN THOUSANDS 2022 2021 $ % Reported Gross Profit $38,796 $27,499 $11,297 41% Amortization of Intangible Assets Resulting From Purchase 5,102 4,987 115 2% Accounting Adjustments Equity-based Compensation 232
Slide 12: GAAP to non-GAAP operating expenses
Reconciliation from GAAP to non-GAAP operating expenses THREE MONTHS ENDED MARCH 31, $ IN THOUSANDS 2022 2021 $ % GAAP Sales & Marketing $21,293 $11,743 $9,550 81% Equity-based Compensation (3,746) (102) ($3,644) >100% Non-Recurring Items (27) (37) $10 (28%) Non-GAAP Sales & Marketing $17,520 $11,60
Slide 13: Net loss to adjusted operating profit
Reconciliation from net loss to adjusted operating profit THREE MONTHS ENDED MARCH 31, $ IN THOUSANDS 2022 2021 $ % ($13,057) ($10,488) ($2,569) 24% Net (Loss) Income Interest Expense 1,884 8,454 (6,570) (78%) Loss on remeasurement TRA liability 248 -Total Assets 248 Nmf Foreign Exchange Loss/(Gain)
Slide 14: Net income to adjusted EBITDA
Reconciliation from net income to adjusted EBITDA THREE MONTHS ENDED MARCH 31, $ IN THOUSANDS 2022 2021 $ % Net (Loss) Income ($13,057) ($10,488) ($2,569) 24% Interest Expense 1,884 8,454 (6,570) (78%) Loss on remeasurement TRA liability 248 - 248 Nmf Total Assets (Benefit) provision for income taxe
Slide 15: Net loss to adjusted net income
Reconciliation from net loss to adjusted net income THREE MONTHS ENDED MARCH 31, $ IN THOUSANDS 2022 2021 $ % Net (Loss) Income ($13,057) ($10,488) ($2,569) 24% Non-recurring provision for income taxes 392 - 392 Nmf Loss on remeasurement TRA liability 248 - 248 Nmf Transaction Expenses 1,310 38 1,27
Slide 16: Cash flow from operations to unlevered free cash flow
Reconciliation from cash flow from operations to unlevered free cash flow THREE MONTHS ENDED MARCH 31, $ IN THOUSANDS 2022 2021 $ % Cash Flow from Operations $13,633 $13,527 $106 1% Cash interest 1,771 8,039 ($6,268) (78%) Transaction expenses paid in cash 1,310 38 $1,272 >100% Earnout payment 6,400
Slide 17: Basis of presentation
Basis of presentation TAM: TAM or “Total Addressable Market” refers to the revenue opportunity that we believe is available for Non-GAAP General & Administrative: is calculated as GAAP General & Administrative expense less equity- our healthcare commercial intelligence platform, a subset of the Glob
Definitive Healthcare — Q1 2022 Earnings Presentation on 6ix